Trial ID or NCT#



not recruiting iconNOT RECRUITING


This is a Phase 1, open-label, dose escalation study in women with primary, non-recurrent breast cancer undergoing surgery. AVB-620 will be administered prior to surgery.

Official Title

A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No


Irene Wapnir, MD
Irene Wapnir, MD
Surgical oncologist, Breast surgeon, Breast specialist
Professor of Surgery (General Surgery)
Frederick M. Dirbas, MD
Frederick M. Dirbas, MD
Surgical oncologist, Breast surgeon
Associate Professor of Surgery (General Surgery)

Contact us to find out if this trial is right for you.


(650) 498-7061